title: Severe left ventricular hypertrophy in pediatric dialysis: prevalence and predictors.
abstract: Left ventricular hypertrophy (LVH) has been recognized as an independent risk factor for cardiovascular morbidity and mortality in adults with end-stage renal disease. However, the prevalence and severity of LVH in children on chronic dialysis therapy is not well established. Retrospectively, 64 chronic dialysis patients, aged 20 months to 22 years, on chronic dialysis had echocardiographic evaluation of LV mass (LVM) and geometry. Forty-eight (75%) children had LVH, including 22 of 26 (85%) on hemodialysis (HD) and 26 of 38 (68%) on peritoneal dialysis (PD). The prevalence of LVH in patients on HD was significantly higher than those on PD (P=0.02). Abnormal LV geometry was found in 51 of 64 (80%) patients: 25 patients (39%) had eccentric hypertrophy, 3 (5%) had concentric remodelling, and 23 (36%) had concentric LVH. Twenty-six children (41%) had severe LVH, defined as LVM index greater than 51 g/m2.7, which is associated with a fourfold greater risk for development of cardiovascular disease in adults. Patients with severe LVH had a significantly lower hemoglobin level (P=0.027) and longer duration of renal disease prior to the start of dialysis therapy (P=0.003) than patients without LVH. Multiple logistic regression analysis revealed HD as opposed to PD as a significant independent predictor for severe LVH (P=0.036). Higher systolic blood pressure remained in the final model as an independent predictor with a borderline level of significance (P=0.065). The results indicate that severe LVH and abnormal left ventricular geometry are common in young dialysis patients. Better control of blood pressure, anemia, and hypervolemia may be important in prevention or improving LVH.
authors.affiliation: Division of Nephrology and Hypertension, University of Cincinnati College of Medicine and The Children's Hospital Research Foundation, Ohio 45229-3039, USA. mitsm0@chmcc.org
authors.forename: M M
authors.initials: MM
authors.lastname: Mitsnefes
authors.forename: S R
authors.initials: SR
authors.lastname: Daniels
authors.forename: S M
authors.initials: SM
authors.lastname: Schwartz
authors.forename: R A
authors.initials: RA
authors.lastname: Meyer
authors.forename: P
authors.initials: P
authors.lastname: Khoury
authors.forename: C F
authors.initials: CF
authors.lastname: Strife
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D003430:Cross-Sectional Studies; D004452:Echocardiography; D005260:Female; D005544:Forecasting; D006801:Humans; D017379:Hypertrophy, Left Ventricular / Q000000981:diagnostic imaging / Q000453:epidemiology* / Q000209:etiology*; D007223:Infant; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000628:therapy*; D008297:Male; D010530:Peritoneal Dialysis; D015995:Prevalence; D006435:Renal Dialysis; D012189:Retrospective Studies; D012720:Severity of Illness Index